Business description
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Management board & Supervisory board
CEO |
Paul Hudson |
Management board |
François-Xavier Roger, Houman Ashrafian, Natalie Bickford, Olivier Charmeil, Brian Foard, Emmanuel Frenehard, Brendan O’Callaghan, Roy Papatheodorou, Madeleine Roach, Thomas Triomphe, Julie Van Ongevalle |
Supervisory board |
Frédéric Oudéa, Paul Hudson, Christophe Babule, Clotilde Delbos, Rachel Duan, Carole Ferrand, Lise Kingo, Patrick Kron, Wolfgang Laux, Barbara Lavernos, Fabienne Lecorvaisier, Anne-Françoise Nesmes, Gilles Schnepp, John Sundy, Ceng-Yann Tran, Emile Voest, Antoine Yver |
Company data
Name: |
Sanofi S.A. |
Address: |
54, Rue La Boétie,F-75008 Paris |
Phone: |
+33-1-53-77-40-00 |
Fax: |
+33-1-53-77-43-03 |
E-mail: |
-
|
Internet: |
https://www.sanofi.com/ |
Industry: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Sub sector: |
Pharmaceuticals |
End of financial year: |
12-31 |
Free Float: |
88.70% |
IPO date: |
- |